GS
ADILW

GTS Securities’s Adial Pharmaceuticals Warrant ADILW Stock Holding History

GTS Securities’s Portfolio ADILW Stock Details ADILW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-14,401
Closed -$86 – 4210
2023
Q2 		$86 Buy
+14,401
New +$327 ﹤0.01% 1214

GTS Securities's ADILW Position: Q3 2023 in Review

GTS Securities sold out of Adial Pharmaceuticals Warrant (ADILW) in Q3 2023, closing a stake of 14,401 shares — an estimated $86 sold.

GTS Securities first reported a position in ADILW in Q2 2023 and held it in 1 quarter. The position peaked at $86 in Q2 2023. 0 funds tracked by Wall St. Rank hold ADILW as of Q3 2023.

  • GTS Securities reported no remaining Adial Pharmaceuticals Warrant position as of Q3 2023 after selling out during the quarter.
  • GTS Securities sold 14,401 Adial Pharmaceuticals Warrant shares in Q3 2023, an estimated $86.
  • GTS Securities first reported a position in Adial Pharmaceuticals Warrant in Q2 2023 and held it in 1 quarter.
  • GTS Securities's Adial Pharmaceuticals Warrant position peaked at $86 in Q2 2023.
  • 0 funds tracked by Wall St. Rank held Adial Pharmaceuticals Warrant as of Q3 2023.

Based on GTS Securities's 13F filing for Q3 2023, filed 15 Nov 2023.